These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35084989)

  • 1. Hypertrophic Cardiomyopathy: New Concepts and Therapies.
    Maron BJ; Rowin EJ; Maron MS
    Annu Rev Med; 2022 Jan; 73():363-375. PubMed ID: 35084989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
    Maron BJ; Desai MY; Nishimura RA; Spirito P; Rakowski H; Towbin JA; Dearani JA; Rowin EJ; Maron MS; Sherrid MV
    J Am Coll Cardiol; 2022 Feb; 79(4):390-414. PubMed ID: 35086661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
    Maron BJ; Ommen SR; Semsarian C; Spirito P; Olivotto I; Maron MS
    J Am Coll Cardiol; 2014 Jul; 64(1):83-99. PubMed ID: 24998133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hypertrophic cardiomyopathy.
    Enriquez AD; Goldman ME
    Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023.
    Maron BJ; Rowin EJ; Maron MS
    Am J Cardiol; 2024 Feb; 212S():S77-S82. PubMed ID: 38368039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator.
    Maron BJ; Rowin EJ; Maron MS
    Heart Rhythm; 2021 Jun; 18(6):1012-1023. PubMed ID: 33508516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
    J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
    Maron MS; Rastegar H; Dolan N; Carpino P; Koethe B; Maron BJ; Rowin EJ
    Am J Cardiol; 2022 Jan; 163():91-97. PubMed ID: 34785034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
    Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy.
    Maron BJ; Maron MS
    Lancet; 2013 Jan; 381(9862):242-55. PubMed ID: 22874472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices.
    Shirani J; Aurshiya R; Elshaikh A; Olenchock SA; Rowin EJ; Maron MS; Maron BJ
    Am J Cardiol; 2021 Mar; 142():130-135. PubMed ID: 33279482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
    Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N
    Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
    McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
    Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcomes of hypertrophic cardiomyopathy in young adults.
    Baron É; Karam N; Donal E; Puscas T; Mirabel M; Bacher A; Wahbi K; Mazzella JM; Jeunemaitre X; Reant P; Hagège A;
    Arch Cardiovasc Dis; 2021; 114(6-7):465-473. PubMed ID: 33744178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
    Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
    JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy: a systematic review.
    Maron BJ
    JAMA; 2002 Mar; 287(10):1308-20. PubMed ID: 11886323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.
    Maron BJ; Maron MS
    Heart Rhythm; 2016 May; 13(5):1155-1165. PubMed ID: 26749314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.